Healthtech & Wellness VC Funds

GSV Ventures is a female-led venture capital firm that focuses on the global education technology sector, spanning "Pre-K to Gray." Founded by Deborah Quazzo and Michael Moe, the firm invests in transformative learning companies across various stages, with a significant emphasis on digital learning and future of work technologies. GSV Ventures manages $180 million in its second fund and has invested in over 93 companies, including prominent names like Coursera, ClassDojo, Degreed, and Guild Education. The firm's investment strategy targets innovative education technology companies that have the potential to create substantial impact and drive massive digital disruption in the learning sector. GSV Ventures looks for startups that are advancing education through technology, supporting initiatives that range from early childhood education to professional upskilling. The leadership team at GSV Ventures includes seasoned professionals like Claire Crittenden, Mujtaba Wani, and Alexandra Argo, who bring extensive experience from diverse backgrounds in tech, finance, and education.

Gotham Green Partners, founded in 2017 and based in Santa Monica, California, is a private equity firm specializing in the cannabis sector and related industries. The firm leverages decades of institutional investing and operational experience to support its portfolio companies with strategic guidance, operational expertise, and flexible capital solutions. Their investments span various stages of growth, including venture capital, growth equity, structured credit, and special situations. Gotham Green Partners has made significant investments in notable companies such as MedMen, a vertically integrated cannabis operator with marquee stores in high-profile locations, and iAnthus, which operates across multiple states with a focus on CBD products. Other prominent portfolio companies include Lord Jones, known for its luxury CBD products, and Jane Technologies, which offers retail software solutions for the cannabis industry. The firm has a strong track record of successful exits, including the sale of Lord Jones to Cronos Group and the acquisition of HERBL, a major cannabis distributor in California. Gotham Green Partners is led by Founder and Managing Partner Jason Adler, who brings extensive experience in institutional capital allocation and strategic investment​.

Guinness Ventures is a London-based venture capital firm founded in 2010 and part of the Guinness Group alongside Guinness Global Investors. Headquartered at 18 Smith Square, Westminster, the firm has invested more than £340 million into over 200 EIS (Enterprise Investment Scheme), VCT (Venture Capital Trust), and IHT-qualifying companies across the United Kingdom. Tim Guinness serves as Chief Investment Officer, and the broader Guinness Global Investors team comprises 44 people including 9 partners. The firm specializes in Series A funding for UK-based scale-up companies, leads rounds, and looks for businesses with at least £1 million in revenue, strong month-on-month growth, exceptional management teams, and highly defensible business models. Typical check sizes range from £1 million to several million pounds. The firm operates multiple tax-efficient vehicles including the Guinness EIS Fund, Guinness Knowledge Intensive EIS, Guinness VCT, and the Guinness Founders SEIS service. The portfolio spans SaaS, health technology, e-commerce, and business services. Notable investments include Doctify (online medical reviews, £3.8 million total invested since 2019), Shot Scope Technologies (golf performance tech, $4 million contributed to its $8.5 million Series B led by Guinness in July 2024), Popsa (photo books), Fifty (audience intelligence), Wolf & Badger (luxury marketplace), and Cera Care (healthcare and homecare). The firm has achieved seven exits — including Plotbox, Pasta Evangelists, Imagen, ContentCal, Jones Food, and Aptem — returning £34.3 million to investors at an average 2.6x realized return before tax reliefs. Gibson Ventures targets companies with strong fundamentals that also qualify for UK tax-advantaged investment schemes, pairing rigorous investment criteria with the additional investor incentive of SEIS, EIS, and VCT relief to create a compelling proposition for both founders and LPs.

Gutter Capital, an early-stage venture capital firm based in New York City, focuses on investing in companies addressing critical issues such as affordability, economic mobility, and climate change. Founded by Dan Teran, former WeWork executive, and James Gettinger, a computer scientist and former professional gambler, Gutter Capital closed its $25 million Fund I in early 2023. The fund is backed by notable investors including Fred Wilson of Union Square Ventures, Hunter Walk and Satya Patel of Homebrew, and Eileen Murray, former co-CEO of Bridgewater Associates. The firm's portfolio includes investments in sectors such as software-as-a-service (SaaS) and marketplaces. Notable investments include companies like Treehouse, Opus, and The Climate Choice, which focus on clean energy, educational software, and environmental consulting, respectively. Gutter Capital's investment strategy emphasizes backing mission-driven founders and supporting diverse teams, with a significant portion of their investments in women and minority-led startups. Gutter Capital is committed to making an impact by improving accessibility to healthcare, housing, and education, empowering individuals and small businesses, and reducing carbon emissions. The firm typically writes initial checks of $1.5 million and is known for building strong founding teams, having supported a substantial number of hires within its portfolio companies in 2022.

H/L Ventures is a New York-based venture capital firm, established in 2009, that focuses on investing in early-stage companies with a commitment to growth, impact, and diversity. The firm operates as a company-building ecosystem, offering hands-on support to founders through its model of "Daily Active Engagement," helping startups overcome common early-stage challenges. H/L Ventures believes that businesses which create positive societal impact are more likely to succeed, and it particularly supports diverse founding teams, with 84% of its portfolio companies being led by underrepresented groups. H/L Ventures invests across a variety of sectors including climate and energy, healthcare, fintech, and the future of work. Recent investments have included companies like Myavana, a digital haircare assistant powered by AI, and Loliware, a seaweed-based biomaterials company focused on replacing single-use plastics. The firm’s portfolio reflects its mission of investing in businesses that provide innovative solutions to pressing global issues, such as sustainability and equity. With over 100 investments made, H/L Ventures manages a portfolio that spans from pre-seed to growth-stage companies. It recently closed its second early-stage fund, CityRock Fund II, raising $24 million to continue its focus on high-impact, diverse startups that address significant global challenges.

H20 Capital is a dynamic venture capital firm with a strategic focus on early-stage tech companies across the Americas. Based in Miami, Florida, H20 Capital invests predominantly in the U.S., Colombia, and Mexico. Their notable portfolio includes companies like Tul, which specializes in building materials e-commerce, and Felix, a fintech startup providing innovative financial services. H20 Capital's industry focus spans financial services, software, e-commerce, and fintech. They prioritize businesses leveraging technology to disrupt and redefine markets. The firm typically invests in Series A and seed rounds, often co-investing with other prominent venture funds. The investment strategy of H20 Capital emphasizes supporting disruptive entrepreneurs and scalable business models with a strong potential for high returns. Their approach is hands-on, offering not just capital but also strategic guidance and network access. They are known for leading rounds and providing substantial follow-on support to their portfolio companies. Led by partners Daniel Lloreda and Mauricio Porras, the team combines expertise from various sectors including tech, finance, and logistics. The firm’s investment decisions are influenced by their deep understanding of the unique challenges and opportunities within the Latin American and U.S. markets. H20 Capital prefers to engage with startups through direct pitches and fosters relationships through active involvement in the entrepreneurial ecosystem. Their recent $15.5 million investment in Felix highlights their commitment to fintech innovation and their proactive investment approach in 2024.

H2O Venture Partners is an Oxford-based venture capital firm specializing in building high-impact, scalable enterprises from scratch. Their unique approach focuses on sectors like agriculture, health, and environmental technologies, particularly in underserved markets. Notable portfolio companies include Oxitec, known for its genetic pest control solutions, and Fuel3D, a spinout using advanced 3D imaging in healthcare. The firm’s Chariot Fund emphasizes telemedicine and point-of-care technologies, aiming to revolutionize healthcare in developing regions such as India, where these innovations are rapidly adopted. H2O’s strategy is distinct in its "build-from-scratch" model, which involves creating businesses to fill gaps in value chains where no established companies exist. Their investments often target early-stage companies, where they guide ventures through pilot phases into scalable, long-term businesses. The firm is active in East Africa, with a notable presence in Rwanda and Tanzania, in addition to their UK operations. Led by David Kelly and Paul Coleman, H2O places a strong emphasis on commercial discipline and social impact, seeking companies with the potential for both profitability and substantial social benefits. They prefer businesses that are mission-driven, focusing on transforming sectors like smallholder farming and telemedicine. Their hands-on, phased approach to growth helps minimize risk while scaling operations.

Haatch is a Stamford, Lincolnshire-based venture capital firm founded in 2013 by Scott Weavers-Wright and Fred Soneya. The two co-founders met at Kiddicare.com, an online baby care retailer that Weavers-Wright co-founded and grew into one of the UK's largest e-commerce businesses before selling it to Morrisons for £70 million in 2011. Haatch invests strategically at pre-seed and opportunistically at seed in B2B SaaS companies solving deep operational pains, with the stated goal of accelerating companies to their first £1 million in ARR and building the infrastructure to reach £10 million and beyond. The firm manages £80 million-plus in AUM for the 2024/25 tax year and leads rounds. Haatch operates SEIS funds deploying approximately £350K average cheques across 40-plus companies per year, and EIS funds investing approximately £500K average cheques across up to 16 companies per period. The portfolio spans 116 companies, with 103 in tech, 85 in enterprise B2B, 78 in software, and 44 or more in SaaS, valued at £800 million-plus. British Business Investments committed up to £10 million to Haatch in September 2022. The firm achieved four profitable exits in 2025: Re-flow (acquired by Kester Capital in March 2025, returning 6.55x), CareLineLive (acquired by Accel-KKR in May 2025), Tangible Markets (fintech SEIS exit), and a fourth undisclosed exit. Partners include founding partners Weavers-Wright and Soneya, along with Mark Bennett and Jonathan Keeling. Haatch charges no founder fees and positions itself as a genuine operator-investor, drawing on the founders' experience building a scaled e-commerce business to add practical strategic guidance alongside capital. The firm targets 200 or more portfolio companies as it continues to grow its SEIS and EIS vehicles.

Hack VC is a web3-focused venture capital firm headquartered in Incline Village, Nevada, and founded in 2021. The firm specializes in investing in early-stage startups within the cryptocurrency, AI, and blockchain sectors. Hack VC has raised significant funds, including a $150 million venture fund, bringing their total assets under management to approximately $425 million. Notable investments by Hack VC include Jasper AI, a generative AI copilot for enterprises, and Sui by Mysten Labs, which focuses on the secure MOVE programming language for blockchains. Hack VC also supports the decentralized wireless network Helium and Ethereum infrastructure firm Consensys. Their investment strategy targets projects that enhance the usability, scalability, and security of web3, aiming to support the next generation of web3 infrastructure. The firm leverages its hack.labs platform to engage with the protocols they invest in, providing liquidity and support to DeFi pools and other blockchain initiatives. Additionally, Hack VC organizes hackathons and conferences through their hack.summit community, fostering a global network of developers and innovators.

Hadean Ventures is a European life science venture capital firm headquartered in Oslo, Norway, with an additional office in Stockholm, Sweden. They focus on investing in life science startups across Europe, particularly in the Nordics and German-speaking countries. The firm manages approximately EUR 230 million in assets through its two main funds, Hadean Capital I and Hadean Capital II, which collectively exceed their initial targets due to strong investor support. The firm's investment strategy spans across pharmaceuticals, biotech, medtech, diagnostics, and digital health, targeting early to mid-stage companies with the potential to address unmet medical needs. Notable investments include Alex Therapeutics, Arthex Biotech, Complement Therapeutics, Emergence Therapeutics, Ribbon Biolabs, and TargED. Their first successful exit was the acquisition of Emergence Therapeutics by Eli Lilly in 2023. Hadean Ventures is led by Managing Partners Ingrid Teigland Akay and Walter Stockinger, who bring extensive experience in life sciences and venture capital. The team is recognized for its hands-on operational management and strategic guidance, fostering significant advancements in the healthcare sector. For startups seeking investment from Hadean Ventures, it is advantageous to demonstrate strong innovation in addressing critical healthcare challenges and to align with their focus on transformative life science solutions​.

Hakuhodo DY Ventures is the corporate venture capital arm of Hakuhodo DY Holdings, Japan's second-largest advertising and media conglomerate after Dentsu. Founded in 2019 and headquartered in Minato City, Tokyo, the firm invests in companies with innovative technologies and new business models across seed through later stages, with the goal of designing the future alongside its parent company's two business units: Hakuhodo Consumer Brands and Hakuhodo Adhesive Technologies. The team of seven, including four Partners and one Principal, has averaged seven new investments per year over the past five years, completing ten investments in 2024. Hakuhodo DY Ventures focuses on three strategic investment areas: technology that creates new consumer and enterprise touchpoints, areas that extract value from unstructured data, and business domains where social assets are optimally allocated. This translates in practice to software and applications, health technology, AI and deep tech, data analytics, and advertising and marketing. The portfolio has grown to 60 companies as of January 2025, with 54 investments in Japan and 2 in the United States. Check sizes at Series A average $5.41 million per round and at Series B average $27 million per round. Notable portfolio companies include KAKEAI, KOMPEITO (welfare and food-based health management), SOXAI (smart ring for health monitoring), Atlast Health (mental health digital medicine), and Unito (multi-location living rental platform). The firm has produced three portfolio exits: Kuradashi (IPO on the Tokyo Stock Exchange in June 2023, $34.6 million market cap), Cover (IPO on the TSE, $341 million market cap), and Be Marketing (exited November 2023). By embedding within Hakuhodo DY Holdings, the fund provides portfolio companies with access to one of Japan's most extensive advertising and media distribution networks, giving investees a meaningful route to market that an independent VC typically cannot offer.

Hala Ventures is a prominent Saudi-based venture capital firm that focuses on investing in early-stage tech startups, primarily within the MENA region. Founded in 2018, the firm emphasizes sectors such as fintech, e-commerce, SaaS, and logistics. Some of their notable investments include Telfaz11, a creative media studio, and Kaso, a B2B food procurement platform. They actively support startups from Saudi Arabia and neighboring countries, including Egypt and Jordan. Hala Ventures typically targets startups that have achieved sustainable revenue and are scaling their operations. They offer both capital and hands-on strategic support, positioning themselves as a long-term partner for growth. The firm’s leadership, including founding partner Hussain Almarhoon, brings deep expertise in finance and entrepreneurship, ensuring robust guidance for portfolio companies. Their approach to venture investment is rooted in empowering startups through personalized mentorship and building strong ecosystems in the GCC. With a strong track record in fintech and other tech verticals, Hala Ventures continues to be a key player in the region’s burgeoning startup ecosystem.

Halley Venture Partners, founded in 2017 and based in San Francisco, is a venture capital firm that specializes in investing in the legal cannabis and hemp industries. The firm, led by Managing Director Steve Schuman, focuses on early-stage investments, particularly in technology and medical companies that are driving innovation within the cannabis sector. With a background in public and private equity, Schuman and his team bring significant expertise to their portfolio, which includes companies like Willow Industries, Front Range Biosciences, and PathogenDx. Halley Venture Partners typically invests in Seed, Series A, and Series B rounds, supporting startups that are developing scalable solutions and transformative technologies in the cannabis space. The firm is dedicated to building highly scalable businesses, leveraging deep industry knowledge and a hands-on approach to guide companies through the complexities of the rapidly evolving cannabis market. The team at Halley Venture Partners includes experienced professionals like Aaron Taffet, who brings a strong background in private equity and cannabis operations, and advisors such as Ephraim Lindenbaum and Lauren Fraser, who contribute valuable insights from their extensive experience in venture capital and cannabis distributio.

Haload Ventures is a Philadelphia-area family investment office and a-la-carte incubator and accelerator service founded on September 21, 2012 by John Daniel. Operating from the Greater Philadelphia area with an additional presence in Los Angeles, the firm works at the intersection of investing, advising, and building — helping early-stage companies in transportation, shipping, fashion, healthcare technology, and consumer goods develop physical and online technologies, prepare funding documents, and define exit strategies. Daniel has founded three companies himself and executed over 50 deals across technology and healthcare sectors in North America and Europe. Haload targets pre-seed and seed stage opportunities with check sizes typically below $500K, investing from a family office structure rather than through a traditional institutional fund. The firm's three core services — Advising, Building, and Investing — are offered on an a-la-carte basis, which distinguishes it from conventional VC models and allows clients to engage selectively based on their specific needs at each stage of development. Haload operates at modest scale with a limited number of active investments. According to Crunchbase, the firm's operating status has been listed as closed, and recent investment activity has been minimal. The firm's historical contribution has been primarily as an early-stage enabler for entrepreneurs who needed hands-on operational help alongside initial capital, particularly in sectors requiring physical supply chain and distribution expertise.

Halogen Ventures, founded by Jesse Draper in 2015, is an early-stage venture capital firm based in Los Angeles. The firm focuses on investing in female-led consumer technology companies and strategic B2B software sectors. Halogen Ventures has made significant strides with notable investments in companies such as Babylist, Flex, and Ellevest. The firm has raised a total of $31.4 million across its funds and has invested in over 111 companies, achieving 12 successful exits. Their investment strategy includes providing not just capital but also strategic support to help companies grow and scale effectively. They assist with network building, brand exposure, talent acquisition, and subsequent funding rounds. Halogen Ventures is particularly focused on the consumer technology market, driven by the fact that women make 80% of household purchasing decisions. This strategic focus has led to their portfolio companies generating over $10 billion in market value.

Hannah Grey Ventures is a venture capital firm based in Denver, Colorado, with a secondary presence in New York City. Founded in 2020 by Jessica Peltz-Zatulove and Kate Beardsley, the firm focuses on early-stage investments, particularly in pre-seed and seed rounds. The fund primarily targets companies that are reimagining everyday experiences across various sectors including SaaS, healthcare, wellness, fintech, and consumer technology. Hannah Grey is committed to supporting customer-centric founders who are passionate about transforming work and life experiences. They typically invest between $350,000 and $1 million, aiming for a 6-8% ownership stake. The firm often leads or co-leads funding rounds and collaborates with a network of over 6,000 co-investors to build strategic investment syndicates. The firm emphasizes diversity and inclusivity, seeking out founders who reflect the communities they come from. Their investment philosophy includes a strong focus on societal shifts and cultural trends that drive commercial change. Notable investments include companies like UpSmith, Glystn, and Starday Foods. Hannah Grey Ventures aims to be a proactive partner, offering not just capital but also strategic guidance, network access, and operational support to help startups scale effectively. The founders bring extensive experience from their previous roles in corporate venture capital and early-stage investing, making them well-equipped to identify and nurture high-potential startups.

Happiness Ventures is a Palo Alto-based micro venture capital firm founded in 2017 by Ajay Ramachandran, previously Chief Marketing and Product Officer at Dynamic Signal, and Curtis MacDonald, previously Co-Founder and President at hField Technologies. The firm invests in early-stage deep technology companies led by mission-driven entrepreneurs who are not afraid of hard challenges. Happiness Ventures commits $1 million to $5 million per deal at Seed and Series A, and supports startups throughout their entire lifecycle with a long-term investment orientation. The portfolio spans approximately 10 companies across AI and deep tech, enterprise software, health technology, and mixed reality. Named portfolio companies include Chrysalis Cloud (cloud video infrastructure), Particle One (air quality data), Hypersonix (AI-powered revenue optimization), Mae (clinics and outpatient services), onetool (business productivity software), and Mira (AR and mixed reality), which was exited in June 2023. Happiness Ventures concentrates its bets on a small number of high-conviction positions in companies working on genuinely difficult technology problems. Both founders bring hands-on operational backgrounds as former executives and company builders, which shapes the level of strategic engagement the firm offers beyond writing a check. The firm favors founders with a clear mission and the technical depth to pursue it, regardless of whether the problem they are solving is already popular with mainstream venture capital.

Happenco is a Sydney-based modern merchant bank and venture investment firm founded by Ben Cheyne (formerly of Deloitte Ventures), Gideon Gut-Silverman (formerly of Google), and Omar Varts (formerly of Deus Ex Machina). The firm closed its first fund, the Happenco Ventures Fund, at $12 million AUD, focused on empowering the earliest-stage Australian startups. Happenco invests at the minimum viable product stage, supporting portfolio companies to build past initial product-market fit and on to a Series A round, and leads rounds. The fund targets B2B SaaS applications operating in healthcare, construction, critical infrastructure, education, and financial services. The fund has deployed 60% of its capital across 16 companies out of a total portfolio of 27 companies. Notable portfolio companies include Neara (electric utility software), The Spec Sheet (online ad spec management), EdTripper (school excursion platform), Tanna.ai, Musichealth, Prooftec, Earnr, Equip, Neeon, and Ferovinum (wine as an alternative asset class). LPs include former McKinsey Australia and New Zealand managing partner Michael Rennie, Helix Collective founding partner Jeeva Suresh, and the O'Reilly, To, and David family offices. Happenco takes active positions in its portfolio companies and provides strategic counsel through its advisory arm, working closely with founders in various operational capacities beyond providing capital. The firm's founding team brings complementary backgrounds in professional services, technology, and consumer businesses, and the merchant bank structure allows it to support founders across a broader set of financial and strategic challenges than a traditional early-stage fund typically addresses.

Happy Capital is a venture capital firm that specializes in early-stage investments with a focus on high-growth startups across a variety of sectors. Founded with the mission to back passionate entrepreneurs and visionary leaders, Happy Capital prides itself on being more than just an investor. The firm emphasizes a partnership approach, working closely with founders to provide not only financial resources but also strategic guidance and operational support throughout the company's growth journey. Based in France, Happy Capital invests primarily in startups across Europe, focusing on industries such as technology, consumer products, health tech, and sustainability. The firm is particularly interested in companies that have the potential to disrupt traditional markets and bring about significant positive change. With a commitment to innovation and long-term value creation, Happy Capital seeks to identify startups with scalable business models and strong leadership teams. The firm's portfolio is diverse, reflecting its broad investment thesis. Happy Capital has backed companies that range from emerging tech startups to more established businesses that are looking to scale their operations. The firm’s approach is hands-on, with the team often taking active roles in helping their portfolio companies navigate the challenges of scaling, from securing additional funding rounds to expanding into new markets. With a strong network of industry contacts and a team of experienced investors, Happy Capital is well-positioned to help startups achieve their growth ambitions. The firm's focus on sustainability and innovation underscores its commitment to fostering companies that not only achieve financial success but also contribute positively to society. This dual focus on profit and purpose makes Happy Capital a unique player in the venture capital landscape.

Harlem Capital is an early-stage venture capital firm based in New York, dedicated to changing the face of entrepreneurship by investing in 1,000 diverse founders over the next 20 years. Founded in 2015, Harlem Capital focuses on women and minority entrepreneurs, aiming to close the venture capital gap for underrepresented founders. The firm has raised significant capital, with its second fund, Harlem Capital Partners Venture Fund II, closing at $134 million, surpassing its initial target. This fund allows Harlem Capital to invest in 45 companies, primarily at the early seed stage, and maintains a commitment to minority and women founders. The firm targets industries like enterprise and consumer technology and aims for 10%+ ownership stakes in its investments. Harlem Capital's approach includes initiatives like "Culture Carry," which allows founders to share in the fund's carry, promoting a collaborative ecosystem among its portfolio companies. The firm's portfolio includes over 60 investments across various sectors and cities, featuring companies such as Pangaea, CashDrop, and Wellory. The team is led by co-founders Henri Pierre-Jacques and Jarrid Tingle, along with a dedicated group of investors and associates who bring diverse backgrounds and expertise to the firm. Harlem Capital's mission-driven approach and strategic investments aim to foster long-term growth and success for underrepresented founders in the venture capital landscape.

Harrison Metal is a venture capital firm based in San Francisco, founded in 2008 by Michael Dearing. The firm focuses on early-stage investments in technology-driven companies, particularly in the consumer, business services, and developer tools sectors. Over the years, Harrison Metal has attracted a small group of limited partners, including university endowments, charitable trusts, and pensions. Michael Dearing, the founder and General Partner, has a robust background, having worked at eBay, The Walt Disney Company, and Bain & Company before establishing Harrison Metal. He also serves as a Consulting Associate Professor at Stanford University, where he shares his extensive experience in business history and management through various classes offered by Harrison Metal. The firm is notable for its disciplined investment strategy and its support of startups through six funds, providing not just capital but also strategic guidance and operational expertise to help founders navigate the complexities of growing a business.

Hashed is a leading venture capital firm specializing in blockchain technology and Web3 startups. With headquarters in Seoul and offices in Singapore, San Francisco, and Bengaluru, the firm is deeply committed to decentralization and its potential to transform global economies. Hashed supports early-stage founders building innovative decentralized applications (dApps), tools, and infrastructure across industries like finance, gaming, and entertainment. Some of its notable portfolio companies include Aptos, a blockchain infrastructure project, and Republic, a platform for investing in startups and crypto. Hashed is more than just an investor—they act as ecosystem builders, offering hands-on strategic support to their portfolio companies. They also run subsidiaries like Hashed Emergent, which focuses on emerging markets, and UNOPND, an incubator for early Web3 startups. Hashed regularly hosts major blockchain events, including Korea Blockchain Week (KBW), which has become one of Asia’s largest blockchain gatherings. The firm's global network and commitment to fostering decentralized communities have helped them lead the charge in Web3 innovation.

Hatteras Venture Partners, based in Research Triangle Park, North Carolina, focuses on seed and early-stage investments in biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related areas in human medicine. Founded in 2000, the firm has grown significantly and now manages approximately $450 million across multiple funds​. The firm aims to build transformational companies that benefit patients and healthcare professionals, with a strong emphasis on investing in innovative life science companies. Notable investments include G1 Therapeutics, Clearside Biomedical, and GeneCentric​. Hatteras Venture Partners also manages the Venture Capital Multiplier Fund (VCMF), a $60 million fund that co-invests with other venture capital firms to support high-growth companies in North Carolina​. The firm has a proven track record, leveraging relationships with major healthcare institutions like UNC-Chapel Hill, Duke University, and Vanderbilt University to foster innovative startups​.

H/L Ventures (Hatzimemos/Libby) is a New York City-based venture capital firm and company-building platform founded in 2009 by Eric Hatzimemos and Oliver Libby, headquartered at 30 Rockefeller Plaza. H/L was among the first modern venture studios and among the earliest company-building firms focused on startups at the nexus of growth, impact, and diversity. The firm operates through affiliated funds including H/L Studio and CityRock Venture Partners, and leads rounds with a typical investment of approximately $1 million per deal. CityRock Fund I ($17 million, closed 2021) is fully deployed across 15 companies including Andie Swim, Aunt Flow, BlocPower, Group Black, Loliware, Sealed, and Sorcero. CityRock Fund II ($24 million, closed July 2024) focuses on early-stage startups addressing challenges in climate and energy, healthcare, fintech, protective industries, and the future of work. Nearly 85% of CityRock portfolio founders come from underrepresented backgrounds, defined broadly to include gender, race, socioeconomic background, sexual orientation, and military service. The firm has made 117 investments in total, with five acquisitions including Memory Lane, which was acquired by Storied in January 2025. H/L Ventures operates under a model it calls Daily Active Engagement — an unusually intensive level of institutional portfolio support in which the team maintains virtually daily, open-ended contact with every portfolio company. Rather than reserving access to partners for quarterly board meetings, H/L integrates itself into the day-to-day work of building each business, providing strategic guidance, operational support, and network access alongside its capital commitments.

HAX is a venture capital firm focused on hard tech startups, investing in areas like robotics, industrial automation, and sustainability. As part of the larger SOSV ecosystem, HAX supports early-stage founders by providing a $250,000 initial investment along with extensive engineering and prototyping resources. The firm operates out of key locations including Newark, NJ, and Shenzhen, China, offering access to fabrication tools like CNC machining and 3D printing for rapid prototyping. With over 250 startups in its portfolio, HAX has backed notable companies like Formlabs, a leader in 3D printing, and Renovate Robotics, which focuses on automating solar installations. HAX typically invests in pre-seed and seed rounds and follows up with additional funding up to $3 million as startups grow. They are especially hands-on, working closely with founders to iterate and develop market-ready products. If you're a founder working on a hard tech solution and looking for mentorship and investment, HAX's global network and resources can accelerate your startup's journey from prototype to product.

Haystack is an early-stage venture capital firm based in San Francisco, known for backing outlier founders at the earliest stages of their startups. The firm typically invests in pre-seed, seed, and Series A rounds, with investment amounts ranging from $250,000 to $1.5 million. Haystack's investment focus includes sectors such as analytics, data, AI, cloud infrastructure, developer tools, distributed workforce, and other enterprise technologies. Founded by Semil Shah, Haystack has built a reputation for supporting exceptional founders through a robust network of advisors, customers, and talent. The firm's portfolio boasts notable companies like DoorDash, Instacart, Canva, and Dropbox, reflecting its success in identifying and nurturing high-potential startups.

HC9 Ventures is a healthcare-focused venture capital firm based in New York, with an $83 million debut fund aimed at early-stage startups, particularly in healthcare software and services. Their portfolio includes notable investments in Forge Health, Psych Hub, and XP Health, reflecting a focus on businesses that tackle operational challenges for healthcare providers and payers. They typically invest at the Seed and Series A stages, where their community-driven approach can make the most impact. HC9 stands out by leveraging its network of over 125 healthcare executives—leaders from major organizations like UnitedHealth Group and Anthem—who contribute not only capital but also strategic guidance and mentorship to portfolio companies. This unique, hands-on support model helps founders navigate complex healthcare markets and scale their businesses effectively. The fund avoids institutional money, relying instead on personal commitments from these industry veterans, which strengthens the alignment between investors and startups. Co-founded by Richard Lungen, Jon Gordon, and Charlie Falcone, the HC9 team brings over 70 years of combined experience in healthcare and venture building. Their investment strategy focuses on partnering with transformative startups in the U.S., particularly those that align with their community’s expertise. They’re looking for founders who are ready to engage deeply and benefit from industry insight, not just financial backing​.

Headline is a globally recognized venture capital firm with a robust track record in early-stage investments across various industries. Founded in 1999 and headquartered in San Francisco, Headline has established a significant presence in Europe, Asia, and Latin America. Their investment portfolio includes prominent names such as Sonos, Bumble, Farfetch, and SEMrush, highlighting their knack for identifying and nurturing market leaders in sectors ranging from fintech to consumer services and digital health. Headline's strategy is built on a unique technology-driven approach, leveraging proprietary platforms like EVA and ATHENA to identify and evaluate promising startups with precision. EVA uses sophisticated algorithms to monitor over 10 million companies, ensuring early discovery of high-potential ventures, while ATHENA helps in quick and accurate underwriting by analyzing company data to forecast growth trajectories and capital needs. The firm operates regionally-focused funds, including Headline US VII, Headline EU VII, and Headline Brazil III, which collectively raised $954 million in 2022 to support early-stage technology companies. This regional focus allows them to stay close to local markets and trends while maintaining a global perspective and infrastructure. Headline's commitment to diversity is evident, with a strong emphasis on investing in underrepresented founders and creating inclusive work environments. Their team of over 50 investment professionals operates from major cities worldwide, including San Francisco, Berlin, Paris, São Paulo, and Tokyo, bringing a wealth of local and global expertise to their investments. Overall, Headline’s innovative approach and global reach make them a formidable partner for startups aiming to scale and succeed on an international stage.

Heal Capital is a prominent venture capital fund based in Berlin, Germany, that focuses on early-stage investments in the digital health sector. Launched with strong backing from Germany's private health insurance sector, the fund is dedicated to driving digital transformation in healthcare by supporting innovative startups across Europe. Heal Capital typically invests between €1.5 million and €5 million in Seed to Series A rounds, targeting companies that develop solutions to improve patient care and healthcare delivery efficiency. The firm’s investment strategy is centered around digital health, med-tech, and biotech, with a preference for scalable solutions that integrate healthcare with cutting-edge technology. Heal Capital also leverages an extensive network of industry leaders and healthcare professionals to provide strategic guidance to its portfolio companies. Notable companies in Heal Capital’s portfolio include Apheris, a platform for collaborative data ecosystems; CereGate, a company developing computer-brain interfaces; and Gleamer, which uses AI to enhance radiology workflows.

HTH (Health Technology Holding) is a Milan-based venture capital firm specializing in investments within the life sciences sector. Established in 2020 as part of ZCube-Zambon Research Venture, HTH focuses on backing early-stage deep tech startups dedicated to improving human health. The firm’s investment strategy spans a broad range of verticals, including biotech, medtech, digital health, femtech, diagnostics, and consumer healthcare. HTH is particularly interested in companies leveraging cutting-edge technologies such as AI, advanced biotech, and novel medical devices that address unmet needs in healthcare. Their portfolio includes pioneering companies like SOM Biotech, which uses AI to repurpose existing drugs, and Neurofenix, a platform that aids in neurological rehabilitation through innovative sensor technology. The team at HTH is composed of experts from various scientific and technical backgrounds, including statisticians, pharmacists, and biotechnologists. This diverse expertise allows them to provide not only capital but also strategic guidance to their portfolio companies. They focus on fostering innovation that has the potential to make a significant impact on global health, with a special emphasis on scalable and sustainable solutions. HTH’s investments typically range from early to mid-stage companies, reflecting their commitment to nurturing breakthrough innovations from the ground up. The firm also actively collaborates with a wide network of healthcare companies and partners to drive the development and commercialization of transformative health technologies.

HealthCap, founded in 1996 and headquartered in Stockholm, is a European venture capital firm focused on life sciences. The firm invests globally in companies developing breakthrough therapies that address unmet medical needs, particularly in areas like rare diseases, oncology, and genetic disorders. Over the years, HealthCap has backed more than 127 companies, resulting in over 30 approved pharmaceutical products and 50 medical devices, making it one of the largest specialized life sciences investors in Europe. The firm has raised eight funds to date, with over €1 billion in committed capital. HealthCap's portfolio boasts impressive exits, including companies like OxThera and Aprea Therapeutics, and more than 47 of its portfolio companies have gone public. The firm takes an active role in its investments, with partners frequently joining the boards of portfolio companies, guiding them through clinical trials and regulatory processes. HealthCap’s investment strategy emphasizes precision medicine, targeting innovative therapies that improve patient outcomes. With a strong track record of fostering startups into market leaders, the firm plays a crucial role in shaping the future of healthcare.

HealthCare Ventures is a life science-focused venture capital firm founded in 1985 and headquartered at 47 Thorndike Street in Cambridge, Massachusetts. Over more than 35 years, the firm has invested $1.6 billion in more than 100 therapeutic, diagnostic, device, and healthcare technology companies, establishing itself as one of the longest-running healthcare-dedicated VC firms in the United States. Harold Werner serves as Managing Director, and the firm employs approximately 11 people. HealthCare Ventures focuses specifically on pre-clinical or early clinical stage companies with transformative potential in patient care, deploying check sizes in the $3 million to $10 million range across Seed, Series A, and Series B rounds and leading rounds. The firm has made at least 32 tracked investments according to public databases. Portfolio sectors span therapeutics, diagnostics, medical devices, and healthcare technology. A recent notable portfolio exit was Paige, an AI-powered cancer diagnostics company, which exited on August 22, 2025. HealthCare Ventures takes a hands-on approach that goes beyond providing capital: the team actively helps manage portfolio companies, providing operational guidance, strategic input, and scientific expertise throughout the development journey from pre-clinical work to commercialization. The firm's nearly four decades of continuous operation in life science venture investing give it institutional knowledge and relationships across the clinical, regulatory, and commercial ecosystem that span multiple full innovation cycles in biotechnology and medical devices.

HealthQuad is India's leading healthcare-focused venture capital fund, co-founded by Quadria Capital in 2016. The firm targets early-stage investments in companies that are poised to transform the healthcare sector through technological innovation and improved accessibility. HealthQuad's mission is to enhance healthcare affordability, accessibility, and quality in India. The fund recently closed its second fund, HealthQuad Fund-II, raising $162 million, more than double its initial target. This fund focuses on investing in companies that digitize the healthcare value chain, addressing significant gaps revealed during the COVID-19 pandemic, such as the surge in teleconsultations and e-pharmacy usage. HealthQuad's portfolio includes innovative companies like Medikabazaar, THB, HealthifyMe, and ImpactGuru. These investments highlight the fund's commitment to supporting digital health platforms and integrated healthcare financing solutions​. The fund plans to invest in 12-14 companies with individual cheque sizes ranging from $5 to $20 million. Led by co-founders Abrar Mir, Amit Varma, and Charles-Antoine Janssen, HealthQuad leverages extensive industry experience and a robust network to guide its portfolio companies through growth and innovation in the healthcare sector.

HealthQuest Capital, established in 2012 and headquartered in Redwood City, California, is a private asset firm dedicated to providing growth capital to transformative healthcare companies. Their investment focus spans medical devices, diagnostics, digital health, healthcare IT, and innovative services. They prioritize commercial-stage companies that demonstrate proven products or services and require resources to scale effectively. HealthQuest typically invests between $20 million and $100 million per company, often leading the investments and syndicating when necessary. The firm is committed to enhancing patient outcomes and healthcare delivery efficiency, managing approximately $2 billion in assets. The leadership team, spearheaded by founder Garheng Kong, consists of experienced professionals with a combined 300+ years in healthcare investing and operations. Key team members include Randy Scott, Sam Brasch, Sharath Reddy, and Conrad Wang. The firm also boasts a distinguished Board of Advisors featuring notable industry leaders like Regina Benjamin, former U.S. Surgeon General, and Bruce Broussard, CEO of Humana. HealthQuest's portfolio includes companies like Alcresta Therapeutics, Everlywell, Inbound Health, Pulmonx, and TigerConnect. They actively seek investments that offer innovative healthcare solutions and possess the potential for significant growth and impact.

HealthX Ventures is a Madison, Wisconsin-based digital healthcare venture capital firm founded in 2015 by Mark Bakken after his third successful exit. Bakken was subsequently inducted into Wisconsin's Investor Hall of Fame and named among Wisconsin's 275 Most Influential Business Leaders. Located at 551 W. Main Street, Suite 200 — close to Epic Systems' headquarters — HealthX is positioned at the center of one of the country's most concentrated health IT ecosystems. The firm has raised $137 million since its founding, beginning with Fund I, which closed at over $20 million in 2016. WPS Health Solutions is among the LPs. The current portfolio spans 43 companies as of March 2026, and HealthX leads rounds. HealthX invests $1 to $3 million per deal at Seed and Series A, targeting digital health companies with $50K to $100K in monthly recurring revenue. The portfolio has produced one unicorn (Medable) and nine acquisitions, including Agathos, RxLightning, and Geno.Me (acquired in March 2026). Other notable portfolio companies include KeyCare (Epic telehealth platform, which raised $20.9 million in March 2026), Dyania Health ($10 million Series A led by HealthX in October 2024), InsightRX (AI precision dosing deployed across 1,000-plus hospitals), Allergy Amulet (portable food allergen detection), Arcascope (circadian and sleep technology), Sober Sidekick (addiction recovery), Brooklyn Health, and Minset AI. HealthX focuses on solutions that make healthcare more accessible, efficient, and affordable through scalable digital platforms. With deep expertise in health IT, enterprise software, and AI applied to clinical workflows, the firm brings sector-specific operating knowledge to each partnership, helping portfolio companies navigate the complex buyer dynamics and compliance requirements of healthcare markets.

Healthy Venture Capital (Healthy VC) is a premier early-stage investment firm focused on health tech and life sciences startups. With notable investments in companies like Hubble Telemedical and Lineus Medical, Healthy VC is at the forefront of healthcare innovation. The firm targets sub-industries such as telehealth, health data analytics, and digital health platforms, emphasizing technology-driven solutions to enhance patient care. Based in the U.S., Healthy VC invests globally, typically at pre-seed, seed, and series A stages, and often leads funding rounds to foster early growth. The team, including industry veterans like Sean Mendy and Ian Beadle, offers not only financial support but also strategic guidance and access to a broad network of healthcare leaders. For startups seeking investment, it’s crucial to demonstrate a strong technological foundation and a vision for transformative healthcare improvements. Healthy VC values innovations with significant impact potential and scalability in the healthcare sector​.

HearstLab, founded in 2016, is a venture capital firm dedicated to investing in women-led, tech-enabled startups at the pre-seed, seed, and Series A stages. The firm focuses on sectors such as fintech, data analytics, healthcare, transportation, enterprise technology, and media. HearstLab aims to close the gender gap in venture capital funding by providing significant financial support and services to help female founders build scalable, sustainable businesses. The firm has invested in over 70 companies, contributing to a portfolio with an aggregate valuation of $2.4 billion. HearstLab is unique in its approach, offering not only capital but also extensive support services, including business development, legal, marketing, engineering, and product development. This support is further enhanced by their network of over 150 female executives from Hearst’s various businesses who provide mentorship and guidance to portfolio companies. HearstLab is chaired by Eve Burton, who also serves as the Executive Vice President of Hearst. The team includes Vice President Lisa Burton, Co-Lead Beth Devin, and Senior Director Katie Bailey, among others, all dedicated to fostering a strong community for their founders and partners. The firm also runs Pitch HearstLab, a live event series where early-stage female founders can pitch for a chance to secure a $100,000 investment and gain invaluable hands-on support from the HearstLab network. This initiative highlights their commitment to amplifying innovation and visibility for women-led startups​.

Heartcore Capital is a Copenhagen-based venture capital firm specializing in early-stage consumer technology companies across Europe. Founded in 2007, Heartcore has developed a reputation for backing startups that aim to create positive, lasting impacts on people’s lives. The firm has invested in over 100 companies, creating five unicorns and several "soonicorns," with notable portfolio companies like Tink and Peakon. Heartcore primarily focuses on pre-seed to Series A funding, with a strong emphasis on consumer-facing sectors such as health and wellness, fintech, mobility, and education. The firm differentiates itself by exclusively targeting consumer technology, which it sees as a unique opportunity to tap into the massive $11 trillion European consumer market. Their mission is "investing in happiness," and they support founders who aim to build category-defining consumer brands. With offices in Copenhagen, Berlin, Paris, and Stockholm, Heartcore has established a broad geographic reach and deep local expertise. The firm is known for its empathetic approach to venture capital, supporting founders through the ups and downs of the entrepreneurial journey.

Heda Ventures is a venture capital firm established in 2008 with headquarters in San Jose, California, and additional operations in Hangzhou, China. The firm specializes in early-stage investments in cutting-edge industries, particularly focusing on biotechnology, healthcare, and the technology, media, and telecommunications (TMT) sectors. Heda Ventures has built a robust portfolio of over 67 investments, working closely with startups that are driving innovation in areas such as diagnostic equipment, drug discovery, semiconductors, and medical supplies. The firm is known for its strategic approach to investment, aiming to support companies with high growth potential by providing not just capital but also guidance and access to its extensive global network. This approach helps portfolio companies scale effectively and achieve market success. Heda Ventures has also been involved in significant exits, including companies like Just - Evotec Biologics and DeepMap, which highlight its successful track record in the venture capital space. With a deep commitment to fostering innovation, Heda Ventures continues to focus on transformative technologies that address critical challenges in healthcare and technology, positioning itself as a key player in the venture capital landscape. The firm's ability to bridge the gap between the U.S. and Chinese markets further enhances its capability to nurture and grow companies on a global scale.

Helicase Venture is an early-stage life sciences venture capital firm founded in 2018 and headquartered in Boston with an additional presence in San Francisco. The firm focuses on innovative life sciences and Bio-IT companies — businesses at the intersection of engineering, health, and AI — with a mission to work alongside early-stage teams as they navigate developmental milestones and bring therapies to patients. The two-partner team is led by Dr. Richard Tsai, a Founding Member who previously served as a Partner at BioEngine Capital where he headed life science investments and was involved in founding multiple companies, and Dr. Joy Lee as Partner. The firm leads rounds and targets Seed and Series A investments with initial commitments of $1 to $5 million. Helicase manages one fund, Helicase Venture Fund I, which has backed eight companies across the United States, Austria, and China, producing two IPOs and three acquisitions. Notable portfolio companies include AbSci (AI-driven drug and target discovery using deep learning and synthetic biology, which completed a Nasdaq IPO in July 2021 at a $1.45 billion market capitalization), Tangible Science (contact lens technology spanning consumer to smart applications), and Totient (AI-driven biotech leveraging tertiary lymphoid structures for novel tissue-specific antigens and high-affinity antibody therapeutics, which was subsequently acquired by AbSci). Helicase makes investment decisions as a team, with each partner contributing domain expertise across biological sciences and computational technologies, supplemented by a network of scientific advisors. The firm's focus on companies working at the frontier of biology and computation reflects a thesis that the most transformative near-term progress in patient care will come from founders who can move fluidly between wet lab science and data-driven discovery.

Helion Venture Partners is an India-focused early to mid-stage venture capital firm founded in 2006 by Rahul Chandra, Ashish Gupta, Kanwaljit Singh, and Sanjeev Aggarwal. Legally based in Mauritius with its primary office in Gurugram, Helion was described by The Economic Times in 2012 as India's largest domestic venture capital firm. The firm has raised four funds totaling approximately $905 million: Fund I ($140 million, 2006), Fund II ($210 million, 2008), Fund III ($255 million, 2012), and Fund IV ($300 million, 2015). The team currently consists of seven professionals including three Partners, one Venture Partner, and one Principal. Helion deploys $2 to $10 million per investment in early to middle-stage technology-powered businesses, seeking board representation and actively partnering with management on strategy and operations — and leads rounds. The portfolio spans 85 companies with two unicorns, six IPOs, and 39 acquisitions. Key sectors include e-commerce, mobile, fintech, healthcare, education, enterprise software, mobility, and consumer services. Notable portfolio companies and exits include Flipkart (the Indian e-commerce unicorn), Myntra (fashion e-commerce, acquired by Flipkart), MakeMyTrip (travel, IPO 2010), RedBus.in (bus ticketing, acquired by Naspers in 2013), BigBasket ($32.8 million Series B in 2014), Toppr ($10 million investment in 2015), and MoEngage (latest investment, December 2025). IndiQube was the most recent portfolio exit, in July 2025. Helion operates as a true partner to portfolio management teams, combining financial capital with operational depth and the long-standing India market knowledge that comes from nearly two decades of continuous investing across multiple economic cycles. The firm's four-fund track record and breadth of exits across diverse consumer and B2B sectors make it one of India's most established institutional venture platforms.

Hemi Ventures is an early-stage venture capital firm headquartered in San Francisco, focused on investing in transformative technologies that shape the future. Their portfolio boasts notable investments in companies such as Plus.ai, a leader in autonomous trucking technology, and Ample, which revolutionizes electric vehicle battery swapping. Hemi Ventures targets industries including autonomous vehicles, artificial intelligence, biotechnology, and advanced manufacturing, providing critical support to startups at the cutting edge of innovation. The firm's investment strategy centers on seed and Series A funding rounds, typically leading these rounds with substantial financial backing and strategic guidance. With an average check size around $3 million, Hemi Ventures actively partners with entrepreneurs to ensure growth and success. They emphasize a hands-on approach, offering not just capital but also access to their extensive network and expertise in scaling businesses. Key figures at Hemi Ventures include founder and managing partner Amy Gu, who brings a wealth of experience in both the tech industry and venture capital. The firm’s leadership is deeply involved in fostering innovation and supporting startups through every stage of their development. For startups seeking investment, Hemi Ventures values groundbreaking ideas with clear market potential and strong technological foundations. Approaching them with a well-defined vision and a robust plan for growth is essential. They prefer to engage with companies that have the potential to redefine industries and drive substantial advancements in their respective fields.

Hemisphere Ventures is a venture capital firm based in Mercer Island, Washington, that focuses on pre-seed and seed-stage investments in cutting-edge technologies. Founded in 2014, the firm primarily invests in sectors like software, biotech, space tech, robotics, drones, and nanotechnology. Their portfolio includes companies like PlanetiQ, Axiom, and Finless Foods, which are leading advancements in space exploration, synthetic biology, and sustainable food production. Hemisphere Ventures actively seeks out companies that are pushing the boundaries of science and technology, often in niche but high-potential areas like space travel, advanced AI, and biotech innovations. They aim to provide not just capital but strategic guidance to help startups scale rapidly. The firm is known for supporting companies that have strong potential to reshape industries and create long-term societal impact. The team at Hemisphere Ventures consists of experienced founders, operators, and investors, who bring decades of expertise in building and scaling businesses across various industries. Their investments reflect a deep interest in transformative technologies with a global reach, helping startups grow at an unprecedented pace.

Henkel Tech Ventures, established in 2016 and headquartered in Düsseldorf, is the corporate venture capital arm of Henkel Adhesive Technologies. The fund primarily targets startups in Europe, North America, and the Asia-Pacific region, focusing on innovative solutions in adhesives, sealants, and functional coatings. Notable investments include ioTech, which developed a high-speed, multi-material additive manufacturing technology, and 3RT, which has created a robotic process for converting wood residue into high-quality hardwood products. Henkel Tech Ventures invests up to 5 million euros in early-stage startups, offering not only capital but also access to Henkel’s extensive global network and technical expertise. Their strategy emphasizes long-term collaboration, leveraging Henkel’s market and technology know-how to drive mutual growth. The fund looks for scalable technologies that complement Henkel’s existing portfolio and foster sustainable innovations. The team is led by Paolo Bavaj, Head of Corporate Venturing, who emphasizes scouting for technologies that enhance Henkel's core markets, such as electronics and engineered wood solutions. Startups benefit from mentorship by Henkel's top management and consulting by their technology experts, ensuring they receive both strategic and operational support. Recent investments include Direct-C, which specializes in hydrocarbon leak detection, and Smartz AG, which offers IoT solutions for adult care. Henkel Tech Ventures is a crucial partner for startups looking to revolutionize industrial applications through advanced materials and sustainable technologies.

HenQ Ventures, founded in 2004 and based in Amsterdam, is a venture capital firm that specializes in early-stage investments in B2B software startups. The firm typically invests in pre-seed to Series A rounds, with investment sizes ranging from €1 million to €10 million. HenQ is known for its focus on unique and unconventional business models and markets, backing founders with strong passion and innovative approaches. HenQ's portfolio includes notable investments in companies like CloudTalk, a cloud-based call center software, and Mews, a hospitality property management system. Other significant investments are in companies like Malou, a restaurant marketing platform, and Stravito, a market research management tool. The firm has had several successful exits, including Impraise, a people enablement platform, and Aidence, an AI solution for radiologists. HenQ is committed to providing extensive support to its portfolio companies, helping them with hiring, fundraising, and setting strategic targets. The firm aims to invest in only a few companies each year, ensuring a high level of involvement and support for each investment. Their approach emphasizes the importance of not over-diluting startups while enabling them to grow sustainably.

Heran Partners, founded in 2020 and based in Antwerp, Belgium, is a venture capital firm focusing on MedTech and HealthTech ventures. Their mission is to fuel the growth of innovative technologies at the intersection of life sciences and data. They support startups and scale-ups that develop disruptive innovations ranging from medical devices to AI solutions for diagnostics and patient monitoring. Heran Partners has a strategic investment approach, targeting key drivers in healthcare such as the need for insightful data, cost-effective solutions, and personalized medicine. The fund typically invests up to EUR 5 million in early-stage companies, offering not only financial support but also strategic guidance, scientific expertise, and a strong network to maximize the ventures' potential. Notable investments include companies like Icometrix, which uses AI to quantify brain structures from MR and CT scans, and Hypervision Surgical, an advanced surgical imaging and data analytics platform. The fund has also seen successful exits, including BlueBee and PharmaFluidics. The team is led by experienced professionals like Annie Vereecken, a serial life sciences entrepreneur, Katleen Vandersmissen, Herman Verrelst, and Joris Mortelmans. They emphasize building long-term relationships with their portfolio companies, growing hand-in-hand with founders and management teams. Heran Partners actively co-invests with other venture capital firms to leverage complementary skills and networks, positioning themselves as a key player in the European HealthTech investment landscape​.

Heritas Capital is a Singapore-based private equity and venture capital firm that focuses on high-growth sectors such as healthcare, education, and technology. Established in 1997, the firm has evolved into a key player in impact investing, driven by its philosophy of “Invest with Purpose, Impact Across Generations.” The firm manages a diverse portfolio of investments, backing companies that aim to create positive social and environmental change while delivering sustainable financial returns. Heritas Capital actively supports ventures across Asia through a multi-stage investment platform, targeting seed to growth stages. It has been involved in significant funding rounds for companies like Holmusk, Hummingbird Bioscience, and Cakap, addressing needs in areas such as digital health, biotech, and edtech. The firm also partners with organizations like SEEDS Capital to co-invest in promising startups, helping scale impact-focused innovations. Heritas Capital’s approach includes a strong commitment to improving access to healthcare and lifelong learning while leveraging technology to drive efficiencies in industries like foodtech and urban solutions. By aligning with partners who share their vision, Heritas ensures that their investments have a long-lasting, generational impact.

Heuristic Capital Partners is an early-stage venture capital firm based in Santa Clara, California. Established in 2016, the firm focuses on investments in hardware-centric startups, especially within the health tech, robotics, medtech, and consumer electronics sectors. The firm aims to support companies through critical stages such as prototyping, financing, manufacturing, and scaling up their businesses. Heuristic Capital Partners has made 46 investments, with notable exits including companies like Lucira Health and LARQ. They provide a hands-on approach, leveraging over 25 years of professional and personal venture investment experience from their three managing directors: Michael Liao, Ren Du MD, and Shu Cao. This team brings a wealth of experience from startup challenges to IPOs and mergers. Their investment strategy is rooted in practical problem-solving and creativity, aiming to help startups overcome hurdles and achieve growth. The firm has raised $34 million for their first venture fund, emphasizing their commitment to supporting early-stage hardware innovations​.

HEXA Global Ventures is a venture capital firm founded in 2019 and headquartered in Richardson, Texas, led by CEO Maan Hamdan. The firm invests in SaaS technology companies across artificial intelligence, machine learning, B2B software, e-commerce, HR technology, and healthcare, primarily at Seed and Series A. Beyond funding, HEXA provides portfolio companies with strategic advisory services, growth acceleration models, software development services, and access to a global business network. The firm has a presence in both the United States and Lebanon. HEXA has made 27 investments according to CB Insights data. Notable portfolio companies include Insala ($10 million investment in December 2022 for an AI-powered mentoring and career development platform), ReqReadyAI (AI-powered recruitment technology, launched September 2024), Encore Bank (invested April 2024, co-invested with Cadron Capital and Patriot Financial Partners), Partners with Sun (alternative energy, January 2024), 1Money Network (financial software, January 2025), and Kosmos Workforce (human capital services). Modern Message was acquired by RealPage on January 22, 2020, representing the firm's one confirmed portfolio exit. HEXA positions itself as more than a capital provider, offering startups access to technical resources in software development alongside the financial and strategic support typical of early-stage VC. The firm's geographic footprint spanning Texas and the Middle East gives it exposure to founder communities in markets that are less saturated with institutional venture capital than the major US coastal hubs, though the firm's website was reported as inactive as of April 2026.

Hi Ventures (formerly ALL Venture Partners, originally ALLVP and Venture Partners Mexico) is a leading Latin American venture capital firm founded in 2012 and headquartered in Mexico City. The fund manages over $300 million across four funds and leads rounds. Co-founders Federico Antoni (a Stanford GSB faculty member) and Jimena Pardo (a former Meta product growth lead, Kauffman Fellow, and Endeavor Entrepreneur) bring complementary backgrounds in academic entrepreneurship and technology company operations. The firm invests at pre-seed, seed, and Series A in Latin American startups with global ambitions, focusing on fintech, future of commerce, human capital, smart cities, AI, and health technology. The portfolio spans approximately 46 companies with 11 notable exits. Key exits include Cornershop (acquired by Uber in 2021), Atlas (acquired by Remote in January 2026), R2 (acquired by Ant International in October 2025), Flink (acquired by Webull in 2024), Aplazame (acquired by WiZink in 2020), Apli (acquired by iCIMS in 2025), Nubity (acquired by Evertec in 2025), and Aventones (acquired by BlaBlaCar in 2016). Current portfolio leaders include Fintual (Chilean wealth management, with co-investors Sequoia and Kaszek), Mendel (AI expense management, with co-investors Goldman Sachs, Base10, and PayPal), Nuvocargo (US-Mexico logistics, co-investors NFX and QED), and Yana (mental health platform reaching over 14 million people). Recent investments include Melian (AI, 2025), Cenit ($1.8 million seed in 2025, SMB tax automation), and Perhaps (2024, co-led with Bessemer Ventures). Hi Ventures also launched a dedicated AI fund focused on Mexico. Hi Ventures operates from the conviction that Latin America's most consequential companies will be built by founders who combine deep local market understanding with ambitions to compete globally. The firm's track record of exits to international acquirers including Uber, Ant International, BlaBlaCar, and Remote validates the quality and global relevance of the companies it backs.